DRAGARWQ5,301.00

Dr Agarwals Eye Hospital Limited

· Pharma & Health
₹ CrorePeersKMCSHILKOVAILOTUSEYEGPTHEALTHGKSLSHALBYINDRAMEDCOARTEMISMED
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation26.639.5
+ Finance Costs7.0
+ Interest Income-2.0-0.8
Changes in Working Capital
+ Inventories-3.8-3.7
+ Trade Receivables — Current-3.7-1.5
+ Trade Payables — Current6.9-0.1
Cash from Operating Activities
Profit Before Tax (per I/S)62.370.793.6
Cash from Operations (pre-tax)103.4114.6
+ Income Taxes Paid13.620.1
Cash from Operating Activities89.894.5
Cash from Investing Activities
+ Disp of Fixed Assets1.00.4
+ Purchase of Investments (Equity / Debt)11.8
+ Interest Received — Investing0.90.1
Cash from Investing Activities-70.0-132.8
Cash from Financing Activities
+ Proceeds from Borrowings15.056.2
+ Repayment of Borrowings7.511.1
+ Payment of Lease Liabilities18.922.9
+ Dividends Paid2.62.4
Cash from Financing Activities-14.216.6
Net Changes in Cash5.5-21.7
Closing Cash32.911.2
Reference Items
EBITDA91.1118.5145.3
EBITDA Margin %28.5229.8430.86
Free Cash Flow (CFO − Capex)89.894.5
Cash Flow to Net Income1.941.73
Cash Paid for Taxes13.620.1
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.